Przejdź do treści
About Us
Company Overview
Immune Modification
In Numbers
Team
Contact Us
Science
Science Overview
Our Treg Platform
Expertise
CAR-Treg Cell Therapy
Multi-Edited, Allogeneic, CAR-Tregs
PolTREG Collaboration
Pipeline
Pipeline overview
Type 1 Diabetes
Neuroinflammatory Diseases
Expanding Our Pipeline
Publications
News
Contact us
Latest press releases
and related news
Harnessing the Power of Regulatory T Cells to Modulate the Immune System
Read the latest
03 June 2025
Launch of Immuthera in the US.
Read more
03 June 2025
Immuthera is attending the BIO Annual Conference
Read more
03 June 2025
3 New Members of Scientific Advisory Board
Read more